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Introduction: In Australia, Aboriginal and Torres Strait
Islander People carry a greater burden of cancer-
related mortality than non-Aboriginal Australians. The
Cancer Data and Aboriginal Disparities Project aims to
develop and test an integrated, comprehensive cancer
monitoring and surveillance system capable of
incorporating epidemiological and narrative data to
address disparities and advocate for clinical system
change.
Methods and analysis: The Advanced Cancer Data
System will integrate routinely collected unit record
data from the South Australian Population Cancer
Registry and a range of other data sources for a
retrospective cohort of indigenous people with cancers
diagnosed from 1990 to 2010. A randomly drawn non-
Aboriginal cohort will be matched by primary cancer
site, sex, age and year at diagnosis. Cross-tabulations
and regression analyses will examine the extent to
which demographic attributes, cancer stage and
survival vary between the cohorts. Narratives from
Aboriginal people with cancer, their families, carers
and service providers will be collected and analysed
using patient pathway mapping and thematic analysis.
Statements from the narratives will structure both a
concept mapping process of rating, sorting and
prioritising issues, focusing on issues of importance
and feasibility, and the development of a real-time
Aboriginal Cancer Measure of Experience for ongoing
linkage with epidemiological data in the Advanced
Cancer Data System. Aboriginal Community
engagement underpins this Project.
Ethics and dissemination: The research has been
approved by relevant local and national ethics
committees. Findings will be disseminated in local and
international peer-reviewed journals and conference
presentations. In addition, the research will provide
data for knowledge translation activities across the
partner organisations and feed directly into the
Statewide Cancer Control Plan. It will provide a
mechanism for monitoring and evaluating the
implementation of the recommendations in these
documents.
INTRODUCTION
Nationally, Aboriginal and Torres Strait
Islander Australians (hereafter ‘Aboriginal
people’) carry a signiﬁcantly greater burden
Strengths and limitations of this study
This mixed-methods study:
▪ Addresses significant gaps in the quality and com-
prehensiveness of cancer data in South Australia,
with a particular focus on cancer among
Aboriginal and Torres Strait Islander people.
▪ Aims to link epidemiological and experiential
data in a unique and sustainable Advanced
Cancer Data System for continuous quality
improvement of cancer care for Aboriginal and
Torres Strait Islander people.
▪ Is underpinned by principles of community
engagement and participation to ensure rele-
vance and utility for the Aboriginal and Torres
Strait Islander Community.
Limitations include:
▪ A reliance on the willingness of data custodians
to release data for inclusion in the Advanced
Cancer Data System.
▪ Difficulty in reaching those Aboriginal and Torres
Strait Islander people who do not take up stand-
ard medical care, due to recruitment occurring
through hospitals and health services. This will
be mitigated by including the service providers
and family members as participants to provide a
broader view of cancer experiences in Aboriginal
communities.
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of cancer mortality than the general population, despite
an equivalent or slightly lower cancer incidence.1
Aboriginal people entering the health system for cancer
treatment tend to be younger, have more advanced
cancer and more lethal types of cancers than
non-Aboriginal Australians.2 3 The drivers of this dispar-
ity are varied, relating to a higher rate of exposure to
risk factors including but not limited to smoking, lower
uptake of cancer screening and higher rates of
comorbidity.4 There is also evidence that once diag-
nosed, Aboriginal people are less likely than other
Australians to receive comprehensive and complete
cancer treatment.5 6 While the non-Aboriginal commu-
nity has experienced improvement in cancer outcomes,
the same improvement has not been observed in the
Aboriginal community, resulting in a widening of the
disparity between Aboriginal and non-Aboriginal
Australians in relation to cancer mortality.2 7
Australia has mandatory reporting requirements for
invasive cancers to registries, with the exception of non-
melanoma skin cancers. State and territory population-
based cancer registries receive information from a
variety of sources including hospitals, pathology labora-
tories, radiotherapy centres and registries of Births,
Deaths and Marriages (BDM).8 For Aboriginal people,
registry data collection is hampered by an inaccurate
and incomplete recording of Aboriginal status, resulting
in inaccuracies in comparisons between states and terri-
tories and assessments of national secular trends, cancer
burden, incidence and survival.9–11 Few Australian
cancer registries routinely record diagnostic stage, which
hampers the ability to adequately interpret comparative
survival outcomes for Aboriginal people and
non-Aboriginal Australians.9 10 Nationally, no registries
routinely record comorbidity—a critical deﬁciency given
that comorbidity can signiﬁcantly inﬂuence the choice
and prescription of chemotherapy and other cancer
therapies, and cancer outcomes.10 12 Treatment data
have also not been collected routinely by registries.
To overcome these deﬁcits, data linkage has been used
in some states in Australia to combine cancer registry and
treatment data.5 9 13–17 These linkage studies have demon-
strated the value of assessing cancer outcomes in relation
to patient treatment, comorbidity and various sociodemo-
graphic features. Work in New South Wales has compared
survival and surgical treatment of Aboriginal and other
Australians with breast, colorectal, non-small cell lung and
prostate cancers by linking their cancer registry records
with hospital admission and death records.13 15–17
However, this practice is not yet incorporated into most
routine registry data collection processes in Australia.
In regard to the experiences of Aboriginal people
with cancer, studies have identiﬁed barriers to care relat-
ing to transport, the hospital environment, separation
from family and country, racism and potentially danger-
ous misunderstandings through language and cultural
differences.6 14 18 19 However, these types of data are not
collected routinely for the purpose of healthcare quality
improvement. Given that healthcare reform is best
guided by the experience of those needing and seeking
its support, the omission of data on Aboriginal experi-
ences of cancer care represents a signiﬁcant gap in the
range of data currently collected. The views and experi-
ences of service providers, although frequently over-
looked, are also critical in focusing on structural and
patient-related issues for reform.
To address these gaps, the Cancer Data and
Aboriginal Disparities (CanDAD) project will develop
and test an integrated, comprehensive cancer monitor-
ing and surveillance system for Aboriginal people in
South Australia, which is likely to have relevance to
other regions. This Advanced Cancer Data System
(ACaDs) will be developed explicitly with Aboriginal
people, to identify prevention strategies and improve the
quality of cancer care provided to Aboriginal people.
The speciﬁc objectives of CanDAD, across three dis-
tinct phases of the research project, include:
Phase 1: Improving the quality and completeness of South
Australian cancer data
1. To ensure accurate and comprehensive recording of
data for Aboriginal and non-Aboriginal people in
South Australia across a range of cancer, cancer
screening, treatment, diagnostic and health service
indicators;
2. To establish methods for accurate, complete and sus-
tainable ongoing monitoring of cancer by type of
cancer, mode of detection and treatment, and for
monitoring outcomes among Aboriginal patients
with cancer;
3. To assess disparities between Aboriginal and
non-Aboriginal South Australians in incidence, mor-
tality, survival, stage, stage-adjusted survival, extent of
comorbidity and technical appropriateness of treat-
ment received, by sociodemographic strata such as
geographic remoteness.
Phase 2: Exploring experiences of cancer care
1. To develop a comprehensive understanding of
patient and provider perspectives on service access,
barriers and enablers to care, service quality, accept-
ability and appropriateness;
2. To develop a brief, culturally sensitive self-report
instrument for recording and quantifying satisfaction
of Aboriginal patients with cancer with system per-
formance that can be deployed as part of routine
service delivery;
3. To prioritise service improvements to enhance
Aboriginal people’s cancer experiences.
Phase 3: Towards an ACaDs
1. To develop a streamlined, integrated data system and
linkage infrastructure for ongoing, timely monitoring
of cancer diagnoses, services and outcomes for
guiding health policy;
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2. To explore the potential for automated cancer data
collation for South Australia into the future and to
collaboratively plan its implementation with partner
organisations.
METHODS AND ANALYSIS
The Aboriginal Community Reference Group (ACoRG)
is playing a key role in ensuring that methodological
processes are culturally appropriate and aligned with
Aboriginal community priorities (ﬁgure 1). The six
members, both female and male, representing different
remote, regional and urban locations across South
Australia, are Elders and cancer survivors with a commit-
ment to doing research the ‘right way,’ as articulated in
the South Australian Aboriginal Health Research
Accord,20 and raising the Community’s role in changing
cancer services. Through regular meetings, the group
will have an opportunity to interpret and translate epi-
demiological and narrative data through Aboriginal cul-
tural lenses.
Phase 1: Improving the quality and completeness of SA
cancer data
Extending work already undertaken during the pilot
phase of the project, the quality and completeness of
data identifying Aboriginal status in the South Australian
(SA) Cancer Registry will be improved by cross-matching
against records from SA Health’s inpatient hospital col-
lection, death registrations and the South Australia-
Northern Territory DataLink’s existing SA Master
Linkage File. Where any records indicate that the
person is Aboriginal, they will be included under broad,
inclusive case criteria. The validity of each case will then
be reviewed for retention and subsequent sensitivity ana-
lysis using more stringent criteria such as country of
birth and family name. Aboriginal people living in
South Australia at the time of their cancer diagnosis
between 1990 and 2010 are estimated to number around
1000 and will be used for methodological Research and
development (R&D) and contribute baseline data for
the ACaDS being developed. Where possible, each
cohort member will be matched to a non-Aboriginal
person on the basis of: (a) year of birth; (b) sex; (c)
year of diagnosis; and (d) cancer type (primary organ
site). A single, randomly selected member will be
included where there are multiple candidates for the
non-Aboriginal cohort. Following this R&D, these initial
data will be used to decide on numbers of
non-Aboriginal people to optimise statistical power in
the prospective data system. Each cohort member’s diag-
nosed cancer will then be manually staged by the SA
Cancer Registry staff using the Surveillance,
Epidemiology, and End Results (SEER) Program
summary stage criteria as an indicator of the extent of
spread of cancer from its point of origin.
In addition to the patient identiﬁer administered by
the SA Cancer Registry, each cohort member will be
assigned a unique and randomly generated project
linkage key, which will attach to any clinical or adminis-
trative record belonging to that individual across all of
the data sets sourced (ﬁgure 2). The use of linkage keys
removes the need for person identiﬁed data to be sup-
plied to, or stored in, the ACaDS integrated data set.
These protocols employ a combination of probabilistic
(linking) and deterministic (merging) techniques to
achieve the highest possible quality of record integration
between these data sets.
Each data set has unique characteristics and ACaDS
integration processes need to be tailored to maximise
the contribution of each to project goals. For example,
the Integrated South Australian Activity Collection
(ISAAC) contains information about inpatient separa-
tions from public and private hospitals in South
Australia. These records are held in four series: public
and private hospital records from the 1990s, and
post-2000. All four series are available to ACaDS in a
de-identiﬁed form stripped of names and addresses but
maintaining a hospital-speciﬁc patient unit record
number (URN), sex, date of birth and residential area
location(s). This enables a consistent, ‘bronze’ standard
integration approach21 for interconnecting an indivi-
dual’s records across hospitals and connecting back to
the health service and URN recorded on the SA Cancer
Registry (operational protocol details are available from
the authors on request). Identiﬁed data are available to
SA-NT DataLink for conducting gold standard integra-
tion of contemporary public hospital records with the
SA Cancer Registry. The results of this linkage are also
available to ACaDS and provide an important means of
assessing the quality of the bronze standard approach
with historic records while facilitating ongoing intelli-
gence on the hospital-speciﬁc URNs associated with
people diagnosed with cancer into the future. The end
result for ACaDS will be the inclusion of valuable mater-
ial on comorbid conditions as well as the treatment and
procedures (cancer and otherwise) experienced by
cohort members.
The remaining South Australian data collections will
make other unique contributions to ACaDS. For
instance, when matched to the SA Cancer Registry using
Figure 1 Governance Structure of Cancer Data and
Aboriginal Disparities (CanDAD), following the South
Australian Aboriginal Research Accord.
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registration numbers from the BDM data collection, the
Cause of Death Unit Record Files will provide
International Classiﬁcation of Diseases (ICD) coded
causes of death for non-cancer deaths. This will be the
ﬁrst use of these data in this way in South Australia, and
will add to the descriptive and interpretative power of
registry data into the future. Also, the Open
Architecture Clinical Information System (OACIS)
Radiotherapy data set will be used to validate and com-
plement data on radiotherapy obtained from the SA
Cancer Registry, ISAAC and national health insurance
data. Other data sets held nationally also have great
potential for informing ACaDS. For example, cohort
members’ health insurance data from the
Pharmaceutical Beneﬁts Scheme (PBS) and Medical
Beneﬁts Schedule (MBS) will help enumerate critical
issues of: chemotherapy uptake; comorbid disease man-
agement in primary care; and actual compared with
recommended treatment pathways.
The process is for data custodians to supply
de-identiﬁed South Australian data with project linkage
keys directly to an ACaDS secure data storage environ-
ment hosted within the South Australian Health and
Medical Research Institute (SAHMRI) and University of
South Australia. The linkage keys will be used to merge
or ‘integrate’ each cohort member’s clinical and adminis-
trative records. They may be used to incorporate any
de-identiﬁed patient-reported experience data gathered
under phase II or later, which could be held as a ﬁeld on
the linked data set, for instance. This best practice
method of data integration will inform analysis of cancer
types, stage, other cancer prognostic characteristics,
comorbidity, clinical management, patterns of care,
health system characteristics (including estimated travel-
ling distances to treatment centres) and, for each
Aboriginal cohort member, patient reported and where
possible provider, family and carer reported experience
(table 1). Commonwealth data will be integrated with
South Australian data and stored for remote data analysis
in the Secure Uniﬁed Research Environment (SURE).22
These data will be used to quantify differences
between Aboriginal and non-Aboriginal Australians with
cancer, regarding: basis of diagnosis; cancer stage at
diagnosis, histopathology grade and other prognostic
characteristics; extent and type of comorbidity;
unadjusted and adjusted survival (adjusted for stage,
grade, other prognostic characteristics and comorbidity);
treatment types and technical appropriateness; and resi-
dential area derived remoteness (Australian Standard
Geographical Classiﬁcation index), socioeconomic status
(Socioeconomic Indexes for Areas) and other sociode-
mographic descriptors. The statistical power will be the
maximum power that these numbers provide. This will
be dependent on the numbers of Aboriginal people
with cancer and the numbers of non-Aboriginal people
chosen for comparison.
Figure 2 Outline of the process from de-identified service and patient outcome data to cohort members to ACaDs. ACaDs,
Advanced Cancer Data System; NT, Northern Territory; OACIS, Open Architecture Clinical Information System; SA, South Australia.
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SA Cancer Registry records augmented with the SEER
summary stage at diagnosis and causes of non-cancer
death will be analysed to address Aboriginal community
questions. Speciﬁcally, Aboriginal people are interested
in knowing why Aboriginal patients with cancer are
more likely to die prematurely than non-Aboriginal
patients. Where they die of non-cancer-related causes,
they are interested in knowing which causes contributed.
Analyses also will address the prevalence of comorbid
conditions and their association with survival outcomes
and patterns of care. Other health and social data sets
already have linkage keys assigned through the SA-NT
DataLink (the SA Master Linkage File) and may allow
ACaDS to describe and quantify broader determinants
of cancer diagnosis, treatment success and survivorship,
including educational, housing, disability and mental
health characteristics.
Phase 2: Exploring experiences of cancer care
In phase 2, qualitative work will involve the collection of
stories from Aboriginal people with experience of
cancer; family members and carers; as well as service
providers working with Aboriginal people with cancer, in
urban, regional and remote locations. This will form the
foundation of a participatory process of questionnaire
development, enabling the inclusion of experiential data
in the Advanced Cancer Data Monitoring System
(ACaDS).23 The stakeholders involved in this process
will include Aboriginal community members, alongside
representatives from governmental and non-
governmental agencies engaged in providing cancer ser-
vices. A concept-mapping process will occur in concert
with the development of a brief Aboriginal Cancer
Measure of Experience (ACME) instrument for record-
ing and quantifying satisfaction of Aboriginal patients
with cancer with system performance, thus contributing
to ACaDS.
The speciﬁc research questions to be addressed in
phase 2 are:
1. What are the barriers and enablers of access, quality
and continuity of care for Aboriginal people with
cancer, as identiﬁed by Aboriginal people themselves,
their families, carers and service providers?
2. When interacting with the health system, what are
the concerns and priorities of Aboriginal people with
cancer, their families, carers and service providers?
3. What constitutes high quality, acceptable and appro-
priate care for Aboriginal people with cancer?
Data collection
Participants will be recruited through Aboriginal Cancer
Care Coordinators at a major metropolitan hospital and
from Aboriginal Community Controlled Health Services
in a mix of purposive and snowball sampling. Care will
be taken to make the sample as broadly representative
as possible of the geographically and culturally diverse
Aboriginal populations within South Australia, and with
regard to age, gender and cancer type. Those who travel
to South Australia for treatment from interstate, as rou-
tinely occurs for patients from the Northern Territory,
will be included in the sample. Based on discussions
with the Aboriginal Health Research Ethics Committee,
and following a brief literature review on ‘timing to
inform recruitment protocols and the conduct of the
interview’, sensitivity will be shown regarding appropri-
ateness of approaches for contacting patients with
Table 1 De-identified data variables to be included in ACaDS
Category Variables
Demographics Age, gender, Aboriginal and Torres Strait Islander status, country of birth, postcode or other location of
residence at diagnosis, residential remoteness and residential-area based measure of socioeconomic
status
Cancer diagnosis Cancer screening histories (for breast, cervix, once the HPV screening register is available, and bowel
cancers), clinical basis of cancer diagnosis, date of diagnosis, primary organ site and morphology (ICD
coded), histopathology grade at diagnosis, breast cancer size (mm/nodal status/focality), and potentially
melanoma thickness and level (note: melanomas will be rare)
Stage at
diagnosis
SEER summary stage (expressed as local, regional or distant degree of spread of solid tumours) and,
where possible, Registry derived TNM stage (derived from pathology forms, hospital narrative reports and
case notes)
Treatment Surgery, surgery type (ACHI codes), surgery date, timing of radiotherapy initiation, chemotherapy and
other systemic therapy start date, agent type (where available) and any other recorded treatments (used
to establish treatment patterns and completeness)
Death Date, cause (ICD coded) and place (major metropolitan public hospital, other public hospital, private
hospital, aged care facility, hospice and home/private residence, extracted by SA Cancer Registry staff
from official death registrations)
Comorbidity ICD coded major ICD disease chapter; comorbidity index (Charlson/other)—primarily derived from public
and private hospital coding, public hospital notes, MBS and PBS claims, and death records
ACaDs, Advanced Cancer Data System; ACHI, Australian Classification of Health Interventions; HPV, human papillomavirus; ICD,
International Classification of Diseases; MBS, Medical Benefits Schedule; PBS, Pharmaceutical Benefits Scheme; SA, South Australia;
SEER, Surveillance, Epidemiology, and End Results; TNM, tumour-node-metastasis.
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cancer at different phases of treatment. Given the
particular emotional factors arising between time of
diagnosis and treatment, participants will not be
approached during that period. Furthermore, with the
varying timelines of individual clinical events,
recruitment may mean approaching patients at various
points postdiagnosis.24–28 Inclusion of participants will
cease at the point of relative data saturation and when
researchers and the ACoRG reach consensus that, as far
as practically possible, the sample is representative in
relation to the categories noted above.
With a view to enabling a culturally safe environment,
participants will be invited to choose between a male,
female, Aboriginal or non-Aboriginal interviewer and to
nominate their preferred interview location. The qualita-
tive (narrative) component of the CanDAD project is
grounded in concepts drawn from participatory action
research and Aboriginal methodologies which move
away from the positivist paradigm towards those that
more closely resemble Aboriginal terms of reference.29 30
The important role of storytelling, or yarning, in
Aboriginal cultures will be honoured by initially provid-
ing participants the time and space to tell their story in
their own words, with their own emphasis.31 32 In this
way, the methods move away from deﬁning needs and
outcomes in terms of established biomedical or func-
tional terms, and towards descriptions that are relevant
to the contexts of Aboriginal communities and life his-
tories.33 Interviews will be audiorecorded, transcribed
verbatim and returned to participants for checking if
requested. Transcripts will be de-identiﬁed prior to
analysis.
Data analysis
Patient journey mapping has been used in various ways
to guide health system review, and to support integrated
and patient-centred care in situations where patients
interact with multiple providers in different settings over
extended periods of time.34–36 For CanDAD, mapping
tools developed for use with Aboriginal patients37 38 will
be adapted to reﬂect the stages of a cancer journey as
outlined in the Statewide Cancer Control Plan39 and
incorporating elements from the Aboriginal and Torres
Strait Islander Companion Document to this plan,40 as
shown in ﬁgure 3. Patient journey mapping enables
stories to be analysed from multiple perspectives, or
according to their component parts, while also maintain-
ing and honouring the narrative as a coherent whole.
This is important in the light of concerns about Western
reductionism that can work against indigenous research
priorities.29 41 Since the term ‘cancer journey’ was not
preferred by the ACoRG, the term ‘patient pathway
mapping’ has been adopted. Within the Statewide
Cancer Control Plan, there are several classiﬁable cir-
cumstances that occur in the prediagnosis, treatment
and post-treatment phases of cancer patient pathways.
However, individual factors such as demographic factors,
patient preferences, access to services and type of cancer
determine if and when these circumstances occur.
Following the methodology used by Graneheim and
Lundman,42 the transcribed text will be divided into
meaning units (categories) reﬂecting the manifest
content of the data, which will be mapped onto the
patient pathway tool (see ﬁgure 3). Steps in the pathway
(columns) will be analysed across multiple participant
narratives so that dominant themes are identiﬁed at
each stage or across stages. Subgroup analysis by gender,
residence (urban, regional, remote), age and cancer
type will be conducted for patients, survivors, family/
carers and service providers. Health service priorities
outlined the Statewide Cancer Control Plan and the
National Aboriginal and Torres Strait Islander Cancer
Framework 2015 will be identiﬁed and compared with
patient and family/carer priorities within and across
narratives.
Underlying themes that emerge across the patient
pathway will also be identiﬁed and described using lan-
guage that closely reﬂects that used by the partici-
pants,42–44 as well as that reﬂecting Aboriginal
understandings of health and well-being.45 46 In this way,
factors that may be important inﬂuences on the patient
pathway, but do not ﬁt neatly into a particular stage, will
be captured. Examples may include deeply personal psy-
chosocial aspects of cancer pathways such as connected-
ness to Culture, Community and Country, family
support, or reﬂections on maintaining well-being in the
face of cancer. Member checking with a subgroup of
interviewees will occur prior to the last round of inter-
views, alongside peer de-brieﬁng. The ACoRG will also
provide speciﬁc attention to the interpretation of data.
At the completion of stage 1, ﬁndings from the patient
pathway and thematic analysis will be presented to a
stakeholder workshop convened for the purpose of
reﬁning the priorities that will drive the concept-
mapping and self-report instrument development out-
lined below.
Concept mapping
Concept mapping23 is a participatory planning tool that
is used to identify service delivery priorities based on
perceptions of Aboriginal people affected by cancer and
cancer service providers. Concept mapping is guided by
a ‘prompt’ question (eg, ‘What action needs to be taken
to improve the quality of Aboriginal patients’ pathway in
the primary healthcare and hospital systems?’). In this
study, the prompt question will be generated by the
Operations Group, ACoRG and project investigators.
The initial pool of strategies for improving the quality of
Aboriginal cancer pathways will be identiﬁed from the
qualitative analysis (in the form of statements) and
reﬁned during the workshop aforementioned.
Following the process outlined by Kane and
Trochim,47 a ﬁnal pool of ∼80 strategies will be sorted
and rated on their perceived importance and feasibility
of implementation in the primary healthcare and
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hospital systems. Ratings will be analysed using multidi-
mensional scaling, hierarchical cluster analysis and
bridging analysis. Pattern matching will provide informa-
tion on how to target intervention strategies to geo-
graphic location (ie, rural, remote, metro) and the
system’s level (ie, individual, family, community, primary
healthcare, hospital). Members from the Operations
Group and the ACoRG will be actively engaged in inter-
preting and translating the results into meaningful local
and statewide actions to improve the quality of
Aboriginal cancer pathways.
Development of the ACME
The concept mapping and development of the ACME
will proceed in parallel, to maximise the relevance and
utility of the self-report instrument while avoiding over-
burdening stakeholders. Since the content and format
of the ACME will be guided by the ﬁndings and the par-
ticipatory process of development, it is not possible to
be prescriptive about its content at this stage. The devel-
opment process will follow Streiner and Norman’s48 pro-
cedures for developing instruments with face validity,
content validity and reliability, and will be informed by
the growing literature on patient-recorded outcome and
experience measures and quality of life measure-
ment.49 50 Domains in the ACME will be identiﬁed on
the basis of the patient pathway mapping and thematic
analysis. The barriers and enablers to care and under-
lying themes will be used to generate item-level state-
ments within each identiﬁed domain. The ACME will be
pilot-tested and reﬁned initially with the involvement of
the ACoRG, then within Aboriginal primary healthcare
settings and ﬁnally by the Aboriginal Cancer Care
Coordinators in the tertiary setting.
Phase 3: Towards an ACaDS
Phase 3 seeks to embed these data sources and methods
into routine cancer data collection and collation, using
data linkage of cancer registry, other routinely collected
data extracts and a service-level recording of self-
reported patient experience of care. These data will be
collated and provide the substrate for extensive partner
feedback and participatory cycles with governance com-
mittees to explore and interpret the ﬁndings. Through
ongoing engagement with cancer service providers,
Aboriginal people and organisations, the partnership
will provide data to assess, test and modify ACaDS pro-
gressively, so that it retains currency and is of high
quality and adaptive to changing needs. ACaDS is
expandable into the future. Additional health and social
data sets will be assessed for relevance to CanDAD’s
future and ongoing aims, as well as efﬁciency and sus-
tainability requirements. Routine standard analyses of
monitoring system data and presentation of results will
Figure 3 Cancer pathway mapping tool.
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be constructed in an attractive/readily interpretable
form for different audiences. Our participatory methods
and partner engagement will be directed at efﬁciently
sustaining the system, data collation, collection and
usage and governance processes into the future.
ETHICS AND DISSEMINATION
The Australian Institute of Health and Welfare (AIHW)
Human Research Ethics Committee (HREC) approved a
proposal to incorporate MBS and PBS data into ACaDS.
The Central Australian Health Research Ethics
Committee (CAHREC) has been approached to approve
the integration of Northern Territory hospital records of
South Australians experiencing cancer diagnoses and
hospitalisation in that territory. The data linkage pro-
cesses will comply with the privacy principles established
by the Population Health Research Network (PHRN). In
addition, operational protocols developed with each
data custodian have been provided to SA Health HREC.
All participants will provide written informed consent
for participation in study interviews.
Findings will be disseminated in local and inter-
national peer-reviewed journals. Proposed research
methods and preliminary ﬁndings have been discussed
at local and international conferences51–57 and in an
invited editorial.58 In addition, CanDAD is providing
data for knowledge translation activities across the
partner organisations, including direct input into the
Statewide Cancer Control Plan and the Aboriginal and
Torres Strait Islander Companion Document.40 It will
provide a mechanism for monitoring and evaluating the
implementation of the recommendations in these
documents.
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